Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Tuesday, April 24, 2018 · 443,763,178 Articles · 3+ Million Readers

Proteinase Activated Receptor 2 - Disease Assessment and Therapeutics Analysis Forecasts to 2024

PUNE, INDIA, March 20, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Proteinase Activated Receptor 2 - Pipeline Review, H1 2018”

Proteinase Activated Receptor 2  

Overview

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.

The latest report Proteinase Activated Receptor 2 - Pipeline Review, H1 2018, outlays comprehensive information on the Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3066586-proteinase-activated-receptor-2-par2-or-coagulation-factor

Top Companies mentioned

Hadasit Medical Research Services and Development Ltd

Heptares Therapeutics Ltd

IB Pharmaceuticals Inc

Proteinase Activated Receptor 2 Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Proteinase Activated Receptor 2    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Proteinase Activated Receptor 2   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Protease activated receptor 2 (PAR2) also known as coagulation factor II (thrombin) receptor-like 1 (F2RL1) is a protein encoded by the F2RL1 gene. PARs (protease-activated receptors) are G-protein-coupled receptors for proteases from the circulation, inflammatory cells and epithelial tissues. PAR2 plays an important role in inflammation and pain.

Proteinase Activated Receptor 2 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Proteinase Activated Receptor 2 - Competitive Analysis

Key players are making innovative developments in Proteinase Activated Receptor 2 industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Proteinase Activated Receptor 2.

The pipeline guide reviews pipeline therapeutics for Proteinase Activated Receptor 2 by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Proteinase Activated Receptor 2 therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Proteinase Activated Receptor 2 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Proteinase Activated Receptor 2.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3066586-proteinase-activated-receptor-2-par2-or-coagulation-factor

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire